RRMS治疗的剂量方案专利如何满足书面描述要求——诺华制药公司诉雅高医疗保健公司的一个教训

{"title":"RRMS治疗的剂量方案专利如何满足书面描述要求——诺华制药公司诉雅高医疗保健公司的一个教训","authors":"Ping-hsun Chen","doi":"10.1089/blr.2022.29285.phc","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How a Dosage Regimen Patent for RRMS Treatment May Satisfy the Written Description Requirement—A Lesson from Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc.\",\"authors\":\"Ping-hsun Chen\",\"doi\":\"10.1089/blr.2022.29285.phc\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":55354,\"journal\":{\"name\":\"Biotechnology Law Report\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology Law Report\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1089/blr.2022.29285.phc\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Law Report","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1089/blr.2022.29285.phc","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}